Completed collaborations

PolyTherics has previously collaborated with the following companies:

Alligator Biosciences to develop the next generation of protein-based therapeutics. See press release.

Avecia to develop the next generation of antibody fragments as therapeutic agents; the project was funded jointly by the companies and was supported by a TSB grant. See press release.

Biocompatibles to enable Biocompatibles’ phosphorylcholine polymer technology to be applied to therapeutic proteins through use of PolyTherics’ TheraPEG™ technology. See press release.

GlycoForm to PEGylate an aglycosyl natural erythropoietin (EPO); the project was funded jointly by the companies and was supported by a TSB grant. Contact Business Development if you are interested in supporting the further development of a PEGylated aglycosyl EPO.

Minapharm Pharmaceuticals, a leading Egyptian pharmaceutical company, for PEGylation of an undisclosed established biological medicine using TheraPEG. See press release.

Isogenica Limited to produce novel high potency peptides for the treatment of inflammatory pain; the project was funded jointly by the companies and supported by a TSB grant.